News | Breast Imaging | February 14, 2023

Upcoming conference to focus on breast density and prediction of advanced and interval breast cancer risk 

Karla Kerlikowske, MD, UCSF professor of Medicine and Epidemiology & Biostatistics

Karla Kerlikowske, MD, UCSF professor of Medicine and Epidemiology & Biostatistics


February 14, 2023 — Breast cancer is now the leading cause of global cancer incidence among women but determining who will develop breast cancer is still a challenge for the medical community. A new tool, developed by researchers from UCSF and several other medical institutions, helps to calculate risk for those who may develop advanced breast cancer that goes undiagnosed despite regular screenings. 

Karla Kerlikowske, MD, UCSF professor of medicine and epidemiology & biostatistics, has been examining risk factors for advanced breast cancer for more than 15 years. She co-leads a consortium of clinicians, researchers and biostatisticians who have developed a risk calculator for advanced breast cancer. 

The Breast Cancer Surveillance Consortium (BCSC) Advanced Breast Cancer Risk Calculator is an interactive tool designed by BCSC scientists to estimate six-year cumulative risk of developing advanced breast cancer based on annual mammography or biennial (every two years) mammography. The calculator is available for clinicians on the web or as iPhone and Android apps. 

Advanced breast cancer is defined as prognostic pathologic stage II or higher. Advanced breast cancers are tumors that are large and/or have spread to lymph nodes or have other characteristics associated with poorer prognosis such as being high grade and estrogen receptor negative. They require surgery and systemic treatment, and detecting breast cancers through screening before they become advanced may avert deaths from breast cancer.  

The breast cancer risk calculator includes factors such as breast density, age, race and ethnicity, family history in a first-degree relative, previous breast biopsies, body mass index, and menopausal status. The calculator provides estimates of very low, low, average, intermediate and high advanced cancer risk to inform decisions about screening frequency and supplemental imaging. 

“The BCSC Advanced Breast Cancer Risk Calculator is easy for physicians to use in clinic on the iPhone or Android smart phone and is particularly informative for women with dense breasts and obesity where annual screening may be indicated,” said Kerlikowske. 

One of the strongest risk factors for advanced breast cancer, apart from having the BRCA gene or a mother or sister with breast cancer, is breast density. Dense breasts have a higher proportion of connective and milk duct tissue. Where the breast is dense, a mammogram of the tissue appears cloudy or opaque. In women with dense breasts, 50% or more of breast tissue appears opaque. Women whose breast density is 75% or more have roughly three to four times the risk of being diagnosed with breast cancer within five years compared with women whose breast density is 25% or less, according to Kerlikowske's research. 

Among the reasons breast density may give rise to advanced breast cancer is that standard screening mammograms have less accuracy with dense breasts than non-dense breasts, making it more challenging to accurately detect the cancer in its earliest stages. On a cellular level, the abundant connective tissue and collagen protein found in normal, dense breast tissue resembles the abnormal proliferation of connective tissue that occurs in the vicinity of cells that have undergone early steps toward becoming cancerous. Certain types of cell signaling between the duct cells and connective tissue may play a role in cancer susceptibility. 

Another strong risk factor for advanced breast cancer is being overweight or obese. More than 50% of women in the U.S. are overweight or obese. Encouraging women to maintain ideal body weight could decrease their chance of advanced breast cancer. 

To share clinical and research insights for breast density and cancer prediction, Kerlikowske and John Shepherd, PhD, of the University of Hawai‘i, are hosting the 10th International Breast Density & Cancer Risk Assessment Workshop  in Hawai’i at the University of Hawai‘i Cancer Center on June 7-9, 2023.

Related Breast Density Content:

Uncertainty About Breast Cancer Risk and Screening Choices and Perceived Risk Heighten with Breast Density Awareness Following Mammography

Creating Patient Equity: A Breast Density Legislative Update

FDA Needs to Ensure that Information on Dense Breast Notifications are Clear and Understandable to all Members of the Public

AI Provides Accurate Breast Density Classification

VIDEO: The Impact of Breast Density Technology and Legislation

VIDEO: Personalized Breast Screening and Breast Density

VIDEO: Breast Cancer Awareness - Highlights of the NCoBC 2016 Conference

Fake News: Having Dense Breast Tissue is No Big Deal

The Manic World of Social Media and Breast Cancer: Gratitude and Grief


Related Content

News | Radiology Business

July 25, 2024 — The radiology gender gap is decreasing, but there remains work to be done, according to an editorial ...

Time July 25, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Flat Panel Displays

July 17, 2024 — LG Electronics (LG) is accelerating its B2B medical device business, expanding its lineup of diagnostic ...

Time July 17, 2024
arrow
Feature | Imaging Technology News - ITN

Be sure to check out the latest digital edition of Imaging Technology News (ITN), featuring the Mobile C-arm Systems ...

Time July 11, 2024
arrow
News | Artificial Intelligence

July 9, 2024 — Lunit, a provider of Artificial Intelligence (AI)-powered solutions for cancer diagnostics and ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
Feature | Radiology Business

The ITN team wishes you a safe and happy 4th of July!

Time July 04, 2024
arrow
News | Breast Imaging

July 2, 2024 — Delphinus Medical Technologies, a pioneering medical imaging company that developed the SoftVue Breast ...

Time July 02, 2024
arrow
News | Artificial Intelligence

June 27, 2024 — Clarius Mobile Health, which provides high-definition handheld ultrasound systems, has obtained U.S ...

Time June 27, 2024
arrow
News | Artificial Intelligence

June 26, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced it ...

Time June 26, 2024
arrow
Subscribe Now